Unclaimed brand
Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world. Our sales and marketing personnel are among the best in the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, we can provide cost savings to the consumer while creating value for all members of the supply chain. Nivagen is focused in three areas of product development: development/co-development, acquisition/in-licensing, and providing sales and marketing services. We are actively looking to partner with CRO and CRAM to co-develop products. We are also acquiring existing products. If you are small FDA qualified manufacturer and want to launch your company or product in the US, Nivagen can provide complete turnkey solutions and cost effective delivery on an accelerated timeline.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#CF2E2E
Persian Red
207, 46, 46
0, 64, 50
0, 78, 78, 19
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#243263
Cloud Burst
36, 50, 99
227, 47, 26
64, 49, 0, 61
Nivagen Pharmaceuticals LLC is a specialty pharmaceutical company focused on developing, manufacturing, and marketing generic and specialty medicines for the North American market. Its portfolio spans prescription and over-the-counter products, sterile injectables, and medicines developed through the FDA’s 505(b)(2) pathway. The company also provides 503B compounding services for institutional customers, with a stated aim of helping address drug shortages.
Based in California, Nivagen operates a 100,000-square-foot cGMP sterile manufacturing facility in Sacramento. Its capabilities include sterile IV bags, vials, prefilled syringes, cartridges, and ophthalmic products, produced using aseptic and terminal sterilization processes. The company offers end-to-end drug development and commercialization support, including formulation and analytical development, manufacturing, supply chain planning, regulatory affairs, and product licensing. Its CDMO services range from custom development and advanced formulation to out-licensing and supply.
Nivagen also pursues partnerships, co-development, acquisitions, and licensing opportunities. Guided by a commitment to integrity, safety, quality assurance, and reliability, the company aims to make high-quality pharmaceutical products available at affordable prices.
